Clinical Trial Update: Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer

View source ↗

Summary

This completed clinical trial examined risk factors and molecular genomics in U.S. patients with chronic liver disease and hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease

Snippet

Sponsor: Stanford University | Conditions: Carcinoma, Hepatocellular | Status: COMPLETED